Open AccessLong-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
Author(s) -
Robert A. Kyle,
Dirk R. Larson,
Terry M. Therneau,
Angela Dispenzieri,
Shaji Kumar,
James R. Cerhan,
S. Vincent Rajkumar
Publication year - 2018
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1709974
Subject(s) - monoclonal gammopathy of undetermined significance , medicine , multiple myeloma , risk factor , confidence interval , population , hazard ratio , gastroenterology , monoclonal , immunology , antibody , monoclonal antibody , environmental health
Monoclonal gammopathy of undetermined significance (MGUS) occurs in approximately 3% of persons 50 years of age or older.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom